688809-97-4 Usage
General Description
3-(Methoxymethyl)piperidine hydrochloride is a chemical compound commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs. It is a piperidine derivative with a methoxymethyl group attached to the piperidine ring. The hydrochloride salt form of this compound is water-soluble and stable, making it suitable for use in the preparation of pharmaceutical products. Its unique chemical structure and properties make it an important intermediate in the production of antipsychotic, sedative, and analgesic medications. Additionally, it has potential applications in the development of novel therapeutic agents and in research studies.
Check Digit Verification of cas no
The CAS Registry Mumber 688809-97-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,8,8,0 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 688809-97:
(8*6)+(7*8)+(6*8)+(5*8)+(4*0)+(3*9)+(2*9)+(1*7)=244
244 % 10 = 4
So 688809-97-4 is a valid CAS Registry Number.
688809-97-4Relevant articles and documents
NOVEL COMPOUNDS AS INHIBITORS OF RENIN
-
, (2012/05/20)
The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to
NOVEL COMPOUNDS AS INHIBITORS OF RENIN
-
Page/Page column 20, (2010/11/05)
The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to
Novel Compounds
-
Page/Page column 47, (2008/06/13)
Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
